Ethical and cross cultural questions concerning pediatric clinical trials

D Pilpel1, F J Leavitt, E Elizur-Leiberman

  • 1Unit of Epidemiology and Evaluation of Health Services, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

This study explores ethical issues in using recombinant growth hormone for children with short stature. It questions informed consent, decision-making autonomy, and potential psychological dependence during long-term treatment.

Area of Science:

  • Pediatric Endocrinology
  • Bioethics
  • Clinical Trials

Background:

  • Recombinant growth hormone (rGH) therapy is used for children with short stature.
  • Ethical considerations arise regarding the use of rGH in otherwise healthy children.

Purpose of the Study:

  • To identify and discuss the ethical dilemmas encountered during a clinical trial of rGH in short, healthy children.
  • To examine issues of informed consent, patient autonomy, and long-term psychological effects.

Main Methods:

  • The study involved a clinical trial of rGH in a cohort of children with short stature.
  • Ethical problems were identified and discussed in a cross-cultural context.

Main Results:

  • Key ethical challenges include balancing benefits and risks, ensuring true informed consent from parents and children, and determining decision-making capacity.
  • Concerns were raised about psychological dependence on medical professionals and the child's freedom to withdraw from long-term treatment.

Conclusions:

  • The use of rGH in children necessitates careful consideration of complex ethical issues, including patient autonomy and the definition of medical necessity versus cosmetic concerns.
  • A cross-cultural perspective is crucial for navigating these ethical dilemmas in pediatric treatment decisions.

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...